Clinical Trial Update: Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib in combination with camrelizumab for advanced chordoma; current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Chordoma, Chemotherapy Effect | Phase 2 | Status: UNKNOWN